Gara Jalqabaatti › Kansarii Prostate › North Carolina › Durham
Qorannoo klinikaalii Kansarii Prostate Durham, NC keessatti
Qorannoo 32 Kansarii Prostate f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University, Durham
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Namoota walitti qabaa jiraSadarkaa 3
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Durham VA Medical Center, Durham
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Namoota walitti qabaa jiraSadarkaa 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Namoota walitti qabaa jiraSadarkaa 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
DESTINY-PANTUMOUR04
Namoota walitti qabaa jiraQorannoo ilaalaa
- Research Site, Durham
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University Medical Center, Durham
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke Cancer Center, Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- fi 1 dabalataa
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Namoota walitti qabaa jiraSadarkaa 2
- Durham VA Medical Center, Durham, NC, Durham
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Durham VA Medical Center, Durham, NC, Durham
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Medical Center, Durham
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center, Durham
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Durham VA Medical Center, Durham
The Vanguard Study: Testing a New Way to Screen for Cancer
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University, Durham
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Medical Center, Durham
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University medical center, Durham
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Namoota walitti qabaa jiraSadarkaa 2
- Duke University Medical Center - Duke Cancer Center, Durham
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Institute, Durham
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Center, Durham
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University, Durham
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · Miili 10 fagaatti
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 4
- Duke University Medical Center, Durham
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Durham VA Medical Center, Durham
- Duke Cancer Network, Durham
- Duke University, Durham
- fi 1 dabalataa
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Durham VA Medical Center, Durham, NC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Institute, Durham
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Center, Durham
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Namoota walitti qabaa jira
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Chapel Hill · Miili 10 fagaatti
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University Medical Center, Durham
Qorannoo Kansarii Prostate magaalota biroo keessatti
- New York City, NYQorannoo 103
- Houston, TXQorannoo 76
- Los Angeles, CAQorannoo 61
- Boston, MAQorannoo 59
- St. Louis, MOQorannoo 46
- Chicago, ILQorannoo 45
- San Francisco, CAQorannoo 45
- Philadelphia, PAQorannoo 44
- Baltimore, MDQorannoo 43
- Nashville, TNQorannoo 42
- Seattle, WAQorannoo 42
- Washington, DCQorannoo 38
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 63
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Kansara MetastatikiiQorannoo 33
- Leukemia Myeloidii HamaaQorannoo 33
- Dhibee QaraQorannoo 32
- Kansarii ColorectalQorannoo 28
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Kansarii OvariiQorannoo 27
- Cufama OnneeQorannoo 26
- Kansarii PancreasQorannoo 24
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.